Treating Medical Critical identification for compliance with Patient safety risk if Specialist Criteria for diagnosis and review notifications are not requirements. provided to the appropriate clinicians To enable notification of initial responsible for patient authorisation and review requirements for care. continuing authorisation to the appropriate medical specialist responsible for patient care. Treatment arrangements: To inform the authorisation assessment. Patient safety risk if information is not Infusion method To ensure appropriate dispense of product provided informs the (intravenous or for the treatment of authorised patients. administration, product subcutaneous) and dosage to treat the Treating facility To enable notification of initial and patient in accordance Administering facility continuing authorisation to the appropriate with prescribed therapy. Dispensing facility dispenser, and where necessary the Product administering facility. Patient weight & height To enable supply planning. Dose amount Dose frequency Date required Treatment plan Review date Clinical outcomes (patient) Medical condition and Build the evidence base for demand An inability to build the indication for use management modelling and future evidence base to evolve iterations for the criteria for access. the Criteria to ensure that patients with medical conditions with proven efficacy receive appropriate therapy. Evidence of clinical Build the evidence base for demand An inability to build the benefit or no clinical management modelling and future evidence base to evolve benefit: iterations of the criteria for access. the Criteria to ensure that patients with medical Supporting evidence conditions with proven including medical test efficacy receive results and measures appropriate therapy. plus the upload of documents. Free text fields for discretionary information. Personal identifying information (requesting medical officer)
Treating Medical Specialist Critical identification for compliance with Criteria for diagnosis and review requirements. To enable notification of initial authorisation and review requirements for continuing authorisation to the appropriate medical specialist responsible for patient care. Patient safety risk if notifications are not provided to the appropriate clinicians responsible for patient care. Treatment arrangements: Infusion method (intravenous or subcutaneous) Treating facility Administering facility Dispensing facility Product Patient weight & height Dose amount Dose frequency Date required Treatment plan Review date To inform the authorisation assessment. To ensure appropriate dispense of product for the treatment of authorised patients. To enable notification of initial and continuing authorisation to the appropriate dispenser, and where necessary the administering facility. To enable supply planning. Patient safety risk if information is not provided informs the administration, product and dosage to treat the patient in accordance with prescribed therapy. Clinical outcomes (patient) Medical condition and indication for use Build the evidence base for demand management modelling and future iterations for the criteria for access. An inability to build the evidence base to evolve the Criteria to ensure that patients with medical conditions with proven efficacy receive appropriate therapy. Evidence of clinical benefit or no clinical benefit: Supporting evidence including medical test results and measures plus the upload of documents. Free text fields for discretionary information. Build the evidence base for demand management modelling and future iterations of the criteria for access. An inability to build the evidence base to evolve the Criteria to ensure that patients with medical conditions with proven efficacy receive appropriate therapy. Personal identifying information (requesting medical officer)
ig-gov-and-system-privacy-impact-assesmt-rprt.DOCX